Long, J., Li, X., Wu, L., Yu, G., Zang, A., Zhao, Y., . . . Fang, J. Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer. Wiley.
Chicago Style (17th ed.) CitationLong, Jieran, et al. Phase Ib/II Study on the Safety, Tolerability, and Preliminary Efficacy of Pegylated Irinotecan (JK1201I) as Second‐line Monotherapy for Patients with Small‐cell Lung Cancer. Wiley.
MLA (9th ed.) CitationLong, Jieran, et al. Phase Ib/II Study on the Safety, Tolerability, and Preliminary Efficacy of Pegylated Irinotecan (JK1201I) as Second‐line Monotherapy for Patients with Small‐cell Lung Cancer. Wiley.
Warning: These citations may not always be 100% accurate.